We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCIC
10251
CALL
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$235K ﹤0.01%
23,900
-2,200
-8% -$21.6K
ATC
10252
DELISTED
Atotech Limited
ATC
$235K ﹤0.01%
12,147
-104,890
-90% -$2.17M
PSB
10253
DELISTED
PS Business Parks, Inc.
PSB
$235K ﹤0.01%
1,258
-7,546
-86% -$1.37M
AGM icon
10254
Federal Agricultural Mortgage
AGM
$2.53B
$234K ﹤0.01%
2,392
+115
+5% +$11.8K
ATXS
10255
CALL
DELISTED
Astria Therapeutics
ATXS
$234K ﹤0.01%
77,900
-111,200
-59% -$499K
AWAY icon
10256
Amplify Travel Tech ETF
AWAY
$32.6M
$234K ﹤0.01%
+13,344
New +$275K
BATT icon
10257
Amplify Lithium & Battery Technology ETF
BATT
$124M
$234K ﹤0.01%
15,979
+2,630
+20% +$39.8K
BFLY icon
10258
PUT
Butterfly Network
BFLY
$2.35B
$234K ﹤0.01%
76,100
-17,700
-19% -$61.1K
CHH icon
10259
PUT
Choice Hotels
CHH
$4.7B
$234K ﹤0.01%
2,100
-2,400
-53% -$312K
DLX icon
10260
PUT
Deluxe
DLX
$1.1B
$234K ﹤0.01%
10,800
-9,800
-48% -$249K
FLUX icon
10261
CALL
Flux Power
FLUX
$12.7M
$234K ﹤0.01%
97,500
+2,200
+2% +$5.43K
HDSN
10262
Hudson Technologies
HDSN
$239M
$234K ﹤0.01%
31,264
+4,773
+18% +$39.4K
OLO
10263
PUT
DELISTED
Olo Inc
OLO
$234K ﹤0.01%
23,700
-38,100
-62% -$415K
OPAD icon
10264
CALL
Offerpad Solutions
OPAD
$21.5M
$234K ﹤0.01%
717
-709
-50% -$476K
RXRX icon
10265
CALL
Recursion Pharmaceuticals
RXRX
$1.69B
$234K ﹤0.01%
28,800
+7,700
+36% +$51.5K
VHI icon
10266
Valhi
VHI
$459M
$234K ﹤0.01%
+5,150
New +$205K
ABCB icon
10267
PUT
Ameris Bancorp
ABCB
$6.02B
$233K ﹤0.01%
5,800
-3,000
-34% -$127K
ACB
10268
Aurora Cannabis
ACB
$233M
$233K ﹤0.01%
17,689
+16,184
+1,075% +$405K
AEVA
10269
PUT
Aeva Technologies
AEVA
$1.62B
$233K ﹤0.01%
14,880
+4,020
+37% +$66.2K
AGZD icon
10270
WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund
AGZD
$135M
$233K ﹤0.01%
+10,232
New +$236K
ELS icon
10271
CALL
Equity Lifestyle Properties
ELS
$12.7B
$233K ﹤0.01%
3,300
-4,100
-55% -$306K
GROW icon
10272
CALL
US Global Investors
GROW
$39.4M
$233K ﹤0.01%
53,100
+2,900
+6% +$14.1K
HNDL icon
10273
PUT
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$638M
$233K ﹤0.01%
11,300
-10,900
-49% -$241K
NMFC icon
10274
CALL
New Mountain Finance
NMFC
$730M
$233K ﹤0.01%
19,600
-1,300
-6% -$16.7K
PSEC icon
10275
PUT
Prospect Capital
PSEC
$1.15B
$233K ﹤0.01%
33,300
-41,100
-55% -$316K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.